• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Dietary supplementation with vitamin D and calcium not associated with reduced cancer risk in older women

byMichael MilliganandQasim Hussaini
March 30, 2017
in Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Vitamin D and calcium supplementation does not result in lower incidence of all-type cancer in post-menopausal women.

Evidence Rating Level: 1 (Excellent)

Study Rundown: With the annual number of new cancer diagnoses and cost of cancer care expected to continue rising over the next decade, cancer prevention is understandably a major public health concern. Since the 1980s, there has been considerable interest in the possible role of vitamin D supplementation in preventing cancer development and progression. The current study was designed as a randomized, placebo-controlled double-blind study to assess the effect of vitamin D3 and calcium supplementation on all-type cancer risk in healthy older women. Approximately, 2303 women (mean age 65.2 years) were randomized into treatment (2000 IU/d vitamin D3 and 1500mg/d calcium) or placebo groups. No significant difference was found between new cancer diagnoses between treatment (45 participants, 3.89%) and placebo (64 participants, 5.58%) groups. Similarly, Kaplan-Meier incidence over 4 years was not significantly between the two groups (0.042 in treatment group vs. 0.060 in placebo group).

Overall, the study suggests that dietary supplementation with vitamin D3 and calcium in post-menopausal healthy older women does not result in lower risk of cancer. The study is limited by its patient cohort consisting of non-Hispanic white women that limits generalizability to other groups and also men. Further, due to the unfeasibility and ethical concerns with asking patients to avoid their own vitamin D and calcium (participants were allowed to take doses not to exceed National Academy of Medicine recommendations) may have biased the study toward null. Future efforts may further evaluate the effect of vitamin D in cancer prevention.

Click to read the study, published today in JAMA

Relevant Reading: The role of vitamin D in reducing cancer risk and progression

RELATED REPORTS

Minimally invasive surgery is beneficial for epithelial ovarian cancer 

2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

In-Depth [randomized clinical trial]: In this randomized, double-blind placebo-controlled study, post-menopausal women—55 years of age and older—were recruited from a population of independently living women in Nebraska between June 2009 and August 2011. Telephone screening was performed and eligible patients were randomized by a statistician using computerized block randomization at their first clinical visit. The treatment group received vitamin D3 (2000-IU capsule, once daily) and calcium carbonate (500-mg tablet, 3 times daily), while the control group received identical placebos. Follow-up visits occurred every 6 months. Primary outcomes comprised of the development of cancer of any type. Prespecified secondary analyses were performed for specific cancers including breast, lung, and colon, rates of cardiovascular disease, colonic adenomas and diabetes. Liaison Analyzer (Diasorin) was utilized to measure baseline serum 25(OH)D level and annual 25(OH)D levels, and annually, serum calcium levels were measured to monitor for hypercalcemia. The current study was powered to detect a 50% reduction in cancer incidence. Approximately, 2303 participants (mean age 65.2 years, 99.5% non-Hispanic white) were randomized into treatment (1156 participants, 50.2%) and placebo (1147 participants). Of all, 2064 (89.6%) completed 4 years of study. Mean adherence to intervention was 75.4% in vitamin D and calcium supplementation group, and 76.6% in the placebo group. Mean baseline 25(OH)D level was 32.8 ng/mL between the two groups, and significantly higher in the treatment group at year 1 (43.9 ng/mL in treatment vs. 31.6 ng/mL in placebo). New cancer diagnosis in treatment (45 participants, 3.89%) and placebo groups (64 participants, 5.58%) were not significantly different (p = 0.06). A similar trend was observed for Kaplan-Meier incidence over 4 years in treatment (0.042; 95%CI 0.032 to 0.056) and placebo (0.060; 95%CI 0.048 to 0.076; p = 0.06) groups. Overall, no serious supplement-related adverse effects were found during the study. Other adverse events included renal calculi (16 in treatment vs 10 in placebo) and elevated serum calcium levels (6 in treatment vs 2 in placebo).

 

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancervitamin d
Previous Post

A virtual glucose management service significantly improved glycemic control in hospitalized patients

Next Post

Recurrent Clostridium difficile infection associated with gastric acid suppression

RelatedReports

All Specialties

Minimally invasive surgery is beneficial for epithelial ovarian cancer 

July 4, 2025
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]

July 2, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

July 2, 2025
Lessons from real-world implementation of lung cancer screening
AI Roundup

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

June 10, 2025
Next Post
Molecular testing for Clostridium difficile may not predict disease activity

Recurrent Clostridium difficile infection associated with gastric acid suppression

Few high school students, young adults get HIV testing

2 Minute Medicine Rewind March 27, 2017

Recurrence of endometrial hyperplasia following medical therapy is common

Laparoscopic hysterectomy equivalent to abdominal hysterectomy in disease-free and overall survival

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]
  • 2 Minute Medicine Rewind July 7, 2025
  • Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.